RNA startup Orna Therapeutics cuts more jobs
Biotech startup Orna Therapeutics has cut more jobs in its second round of layoffs in the last year, STAT has learned.
Orna was part of a buzzy cohort of companies established in the wake of the Covid pandemic, planning to create a new, more durable type of RNA-based medicines. It launched in 2021 and quickly garnered attention from Gilead subsidiary Kite Pharma, Bristol Myers Squibb, Novartis, and Merck.
The company, which is based in Cambridge, Mass., cut an undisclosed number of staff members in the last week, according to posts on social media. The company confirmed the layoffs in a statement, but did not say how many people were affected.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
Related
Lehigh Valley receiving jobs, tourism investment from Shapiro Administration –…
Lehigh, Monroe, and Montgomery counties are among those receiving investments through the Department of Community and Economic Development’s Sports Marketing
Marine Le Pen’s fake jobs trial
Marine Le Pen's political trajectory looks more uncertain than ever after prosecutors called for a temporary ban on the far-right French leader's public office
Women and men agree that cash is king when it…
Employers right now may have the upper hand when it comes to hiring, but many employees are still eyeing the exit. That means that business leaders and HR m
Tencent’s 3,000 new jobs signal new growth in Chinese Big…
Chinese internet giant Tencent Holdings added more than 3,000 jobs in the third quarter, in a sign that the country’s most valuable technology company is on a
